Related Experiment Video

Updated: Jun 22, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
10:03

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory

Published on: February 28, 2013

Prevention of diabetes in hypertensive patients: results and implications from the VALUE trial

Ming-Sheng Zhou1, Ivonne Hernandez Schulman

  • 1Division of Nephrology and Hypertension, Vascular Biology Institute, Nephrology-Hypertension Section, Veterans Affairs Medical Center and , University of Miami Miller School of Medicine, Miami, FL 33125, USA.

Vascular Health and Risk Management
|May 30, 2009
PubMed

Insights

Pharmacological blockade of the renin-angiotensin system (RAS) reduces new type 2 diabetes incidence in patients with cardiovascular disease. RAS inhibition improves insulin sensitivity and glucose metabolism, offering protective effects beyond blood pressure control.

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Pharmacology

Background:

  • The renin-angiotensin system (RAS) plays a crucial role in cardiovascular and metabolic regulation.
  • Pharmacological inhibition of the RAS is a cornerstone in managing hypertension and cardiovascular disease.
  • Emerging evidence suggests a link between RAS blockade and reduced incidence of type 2 diabetes.

Purpose of the Study:

  • To review recent experimental and clinical evidence on the role of RAS inhibition in preventing new-onset type 2 diabetes.
  • To explore the underlying mechanisms by which RAS blockade influences glucose metabolism and insulin sensitivity.

Main Methods:

  • Systematic review of preclinical studies investigating RAS components and glucose homeostasis.
  • Analysis of clinical trial data and observational studies evaluating RAS inhibitors (ACE inhibitors, ARBs) and diabetes incidence.
  • Examination of mechanistic studies focusing on insulin signaling pathways and glucose uptake.

Main Results:

  • Consistent evidence shows that ACE inhibitors and angiotensin type 1 receptor blockers (ARBs) decrease new-onset type 2 diabetes risk.
  • These benefits are observed in patients with hypertension and/or cardiovascular disease, independent of blood pressure reduction.
  • RAS inhibition appears to improve peripheral insulin sensitivity and enhance glucose metabolism.

Conclusions:

  • Pharmacological RAS blockade is a promising strategy for diabetes prevention in at-risk populations.
  • Improved insulin sensitivity and glucose metabolism are key mechanisms mediating the anti-diabetic effects of RAS inhibitors.
  • Further research is warranted to fully elucidate the complex interplay between the RAS and metabolic health.

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...